Literature DB >> 397741

Structure-activity relationships in fusidic acid-type antibiotics.

W von Daehne, W O Godtfredsen, P R Rasmussen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397741     DOI: 10.1016/s0065-2164(08)70148-5

Source DB:  PubMed          Journal:  Adv Appl Microbiol        ISSN: 0065-2164            Impact factor:   5.086


× No keyword cloud information.
  15 in total

1.  Three new fusidic acid derivatives and their antibacterial activity.

Authors:  Shuwei Zhang; Siyuan Wang; Qian Zhang; Cheng-Wei Tom Chang; Jixun Zhan
Journal:  Bioorg Med Chem Lett       Date:  2015-03-20       Impact factor: 2.823

Review 2.  Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

Authors:  Prabhavathi Fernandes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

3.  Novel antimycobacterial C-21 amide derivatives of the antibiotic fusidic acid: synthesis, pharmacological evaluation and rationalization of media-dependent activity using molecular docking studies in the binding site of human serum albumin.

Authors:  Godwin Akpeko Dziwornu; Stephanie Kamunya; Tando Ntsabo; Kelly Chibale
Journal:  Medchemcomm       Date:  2019-04-18       Impact factor: 3.597

4.  Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock.

Authors:  F Genovese; G Mancuso; M Cuzzola; V Cusumano; F Nicoletti; K Bendtzen; G Teti
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

5.  Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.

Authors:  F Nicoletti; P Zaccone; R Di Marco; G Magro; S Grasso; S Morrone; A Santoni; G Tempera; P L Meroni; K Bendtzen
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

6.  Origin and Evolution of Fusidane-Type Antibiotics Biosynthetic Pathway through Multiple Horizontal Gene Transfers.

Authors:  Xiangchen Li; Jian Cheng; Xiaonan Liu; Xiaoxian Guo; Yuqian Liu; Wenjing Fan; Lina Lu; Yanhe Ma; Tao Liu; Shiheng Tao; Huifeng Jiang
Journal:  Genome Biol Evol       Date:  2020-10-01       Impact factor: 3.416

7.  Clinical trial of fusidic acid for lepromatous leprosy.

Authors:  S G Franzblau; G P Chan; B G Garcia-Ignacio; V E Chavez; J B Livelo; C L Jimenez; M L Parrilla; R F Calvo; D L Williams; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

8.  Resistance to fusidic acid in Escherichia coli mediated by the type I variant of chloramphenicol acetyltransferase. A plasmid-encoded mechanism involving antibiotic binding.

Authors:  A D Bennett; W V Shaw
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

9.  Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile.

Authors:  Martin Garcia Chavez; Alfredo Garcia; Hyang Yeon Lee; Gee W Lau; Erica N Parker; Kailey E Komnick; Paul J Hergenrother
Journal:  ACS Infect Dis       Date:  2021-02-01       Impact factor: 5.084

10.  Extensive expansion of the chemical diversity of fusidane-type antibiotics using a stochastic combinational strategy.

Authors:  Xiaojun Song; Jianming Lv; Zhiqin Cao; Huiyun Huang; Guodong Chen; Takayoshi Awakawa; Dan Hu; Hao Gao; Ikuro Abe; Xinsheng Yao
Journal:  Acta Pharm Sin B       Date:  2020-12-15       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.